Ashley Rode
Family · Los Altos, CANPI 1841722543
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,581 of the $1,824 with a category attached, or 86.7%. It is spread thinly across 19 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,078 and has fallen 88.6% since, to $123 in 2025.
Across 81 payments — averaging $22.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$430
- Astellas Pharma US Inc$326
- Novo Nordisk$261
- AbbVie$208
- Lilly USA, LLC$123
- Bayer$68
- plus $408 from 13 others
What the payments were for
- Food & beverage$1,58187%
- Education$24313%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 21 | $430 |
| Astellas Pharma US Inc | 7 | $326 |
| Novo Nordisk | 8 | $261 |
| AbbVie | 15 | $208 |
| Lilly USA, LLC | 1 | $123 |
| Bayer | 2 | $68 |
| Evofem Biosciences, Inc. | 4 | $67 |
| Exact Sciences | 3 | $54 |
| Currax Pharmaceuticals LLC | 3 | $44 |
| Organon | 6 | $35 |
| Axonics, Inc. | 2 | $33 |
| Amgen | 2 | $26 |
| Coloplast | 1 | $24 |
| Mylan Pharmaceuticals Inc. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $23 |
| Therapeuticsmd, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $19 |
| Aspira Women's Health Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$125
- NEXTSTELLIS$117
How this compares
$1,824 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 15 | $578 |
Paid to pharmacies, not to this prescriber.
Other family in Los Altos
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.